Safety of Once-Daily Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol in Japanese Patients with Asthma: A Long-Term (52-Week) Phase III Open-Label Study

Soichiro Hozawa1 Hiroshima Allergy and Respiratory Clinic, Hiroshima, Japan

Hiroyuki Ohbayashi2 Tohno Chuo Clinic, Gifu, Japan

https://orcid.org/0000-0002-5186-8761

Michiko Tsuchiya3 Department of Respiratory Medicine, Rakuwakai Otowa Hospital, Kyoto, Japan

Yu Hara4 Department of Pulmonology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan

Laurie A Lee5 GSK, Collegeville, PA, USA

Takashi Nakayama6 GSK, Tokyo, Japan

https://orcid.org/0000-0003-1948-6373

Jun Tamaoki6 GSK, Tokyo, Japan

Andrew Fowler7 GSK, Brentford, Middlesex, UK

Takanobu Nishi6 GSK, Tokyo, JapanCorrespondence[email protected]

https://orcid.org/0000-0003-2272-6833

show all

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Fulvio Braido, Angelica Tiotiu, Guillermo Guidos-Fogelbach, Ilaria Baiardini, Filippo Cosini, Jaime Correia de Sousa, Andras Bikov, Sylvia Novakova, Marina Labor, Igor Kaidashev, Denislava Nedeva, Krzysztof Kowal, Stefan Mihaicuta, Marilyn Urrutia Pereira, Dirceu Solé, Plamela Novakova, Herberto Chong-Neto, Laura Vrzy, Ignacio J. Ansotegui, Jonathan A. Bernstein, Louis-Philippe Boulet, Giorgio Walter Canonica, Lawrence Dubuske, Carlos Nunes, Juan Carlos Ivancevich, Pierachille Santus, Nelson Rosario, Alexander Emelyanov & Paschalis Steiropoulos. (2022) Manifesto on inhaled triple therapy in asthma: an Interasma (Global Asthma Association – GAA) document. Journal of Asthma 59:12, pages 2402-2412.
Read now

Safety of Once-Daily Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol in Japanese Patients with Asthma: A Long-Term (52-Week) Phase III Open-Label Study

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Safety of Once-Daily Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol in Japanese Patients with Asthma: A Long-Term (52-Week) Phase III Open-Label Study

Citations (1)

Read on this site (1)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date